BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29625247)

  • 1. Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic Investigation.
    Roepman P; Ten Heuvel A; Scheidel KC; Sprong T; Heideman DAM; Seldenrijk KA; Herder GJM; Kummer JA
    J Mol Diagn; 2018 Jul; 20(4):436-445. PubMed ID: 29625247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
    Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
    Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
    Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.
    Goto T; Hirotsu Y; Mochizuki H; Nakagomi T; Shikata D; Yokoyama Y; Oyama T; Amemiya K; Okimoto K; Omata M
    Oncotarget; 2017 May; 8(19):31133-31143. PubMed ID: 28415711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and transcriptomic significance of multiple primary lung cancers detected by next-generation sequencing in clinical settings.
    Yao M; Chen H; Chen Z; Wang Y; Shi D; Wu D; Li W; Huang J; Chen G; Zheng Q; Ye Z; Zheng C; Yang Y
    Carcinogenesis; 2024 Jun; 45(6):387-398. PubMed ID: 38693810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
    Yang R; Li P; Wang D; Wang L; Yin J; Yu B; Li M; Wang S; Wang Y
    Thorac Cancer; 2021 Oct; 12(19):2544-2550. PubMed ID: 34510768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple primary lung cancer: A literature review.
    Romaszko AM; Doboszyńska A
    Adv Clin Exp Med; 2018 May; 27(5):725-730. PubMed ID: 29790681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of large-scale targeted sequencing to distinguish multiple lung primary tumors from intrapulmonary metastases.
    Duan J; Ge M; Peng J; Zhang Y; Yang L; Wang T; Qin T; Yuan R; Zhang Y; Cheng W
    Sci Rep; 2020 Nov; 10(1):18840. PubMed ID: 33139840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
    Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
    Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
    Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
    Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules.
    Rodriguez EF; Tseng LH; De Marchi F; Haung J; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei PB; Lin MT
    Mol Diagn Ther; 2020 Aug; 24(4):461-472. PubMed ID: 32504414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
    Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
    BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing Assisted in Establishing the Diagnosis and Treatment for a Chinese Patient With Breast and Lung Multiple Primary Malignancies.
    Song C; Gao Z; Zong J; Shi J; Yao M; Lu G; Liu X; Wang K; Han L
    J Thorac Oncol; 2018 Jul; 13(7):e109-e111. PubMed ID: 29608968
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of multiple primary lung cancer: a systematic review.
    Xue X; Liu Y; Pan L; Wang Y; Wang K; Zhang M; Wang P; Wang J
    J Int Med Res; 2013 Dec; 41(6):1779-87. PubMed ID: 24265329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases.
    Schweiger T; Starkl V; Glueck O; Glogner C; Traxler D; Jedamzik J; Liebmann-Reindl S; Birner P; Streubel B; Klepetko W; Hoetzenecker K
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1103-11; discussion 1111. PubMed ID: 26503729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis.
    Liu J; Mao G; Li Y; Tao L; Wang W; Peng X; Wang J; Li X; Luan X; Luo R; Huang T; Zhang J; Xu M; Chen S; Wu D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2359-2367. PubMed ID: 32333141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.
    Ono K; Sugio K; Uramoto H; Baba T; Ichiki Y; Takenoyama M; Hanagiri T; Oyama T; Yasumoto K
    Cancer; 2009 Aug; 115(15):3489-500. PubMed ID: 19452548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
    Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
    Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.